We are live on ! Find out more
MTCR

Metacrine, Inc. Common Stock

Delisted

MTCR was delisted on the 8th of February, 2023.

42 hedge funds and large institutions have $105M invested in Metacrine, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

283% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 6

62% more funds holding

Funds holding: 2642 (+16)

17% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 6

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

24% less capital invested

Capital invested by funds: $138M → $105M (-$33.2M)

Holders
42
Holders Change
+16
Holders Change %
+61.54%
% of All Funds
0.74%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
23
Increased
7
Reduced
6
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
NMC
1
NEA Management Company
Maryland
$24.1M
VP
2
venBio Partners
California
$24M
Franklin Resources
3
Franklin Resources
California
$10.3M +$6.36M +693,673 +113%
ACH
4
ArrowMark Colorado Holdings
Colorado
$8.08M -$84K -9,154 -0.9%
AG
5
Artal Group
Luxembourg
$7.27M -$3.53M -384,615 -29%
VA
6
VR Adviser
New York
$5.45M -$4.13M -450,000 -39%
PM
7
Prosight Management
Texas
$4.43M +$408K +44,507 +9%
Fidelity Investments
8
Fidelity Investments
Massachusetts
$3.93M
EC
9
EcoR1 Capital
California
$2.62M
Millennium Management
10
Millennium Management
New York
$2.58M +$2.32M +253,123 +337%
BlackRock
11
BlackRock
New York
$2.27M +$1.83M +199,750 +225%
DM
12
Deerfield Management
New York
$2.18M -$5.96M -650,000 -70%
Alyeska Investment Group
13
Alyeska Investment Group
Illinois
$1.41M -$13.2K -1,438 -0.8%
VC
14
Vivo Capital
California
$1.15M
Vanguard Group
15
Vanguard Group
Pennsylvania
$789K +$187K +20,399 +25%
Northern Trust
16
Northern Trust
Illinois
$611K +$712K +77,648 New
State Street
17
State Street
Massachusetts
$580K +$677K +73,803 New
JP Morgan Chase
18
JP Morgan Chase
New York
$566K +$661K +72,116 New
Geode Capital Management
19
Geode Capital Management
Massachusetts
$375K +$438K +47,776 New
PPA
20
Parametric Portfolio Associates
Washington
$328K +$14.5K +1,581 +4%
AC
21
Apogem Capital
New York
$276K +$322K +35,150 New
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
$254K +$296K +32,253 New
Goldman Sachs
23
Goldman Sachs
New York
$150K -$725K -79,060 -81%
Two Sigma Advisers
24
Two Sigma Advisers
New York
$132K +$154K +16,800 New
Charles Schwab
25
Charles Schwab
California
$109K +$127K +13,800 New

MTCR Hedge Fund Activity: Q4 2020 in Review

42 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Metacrine, Inc. Common Stock (MTCR) for Q4 2020, worth a combined $105M — down 24% from $138M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new MTCR positions and 6 closed out — a net gain of 17 holders — while 7 added to existing stakes and 6 trimmed.

The largest buyer was Franklin Resources, adding an estimated $6.36M. The largest seller was Deerfield Management, cutting an estimated $5.96M.

  • 42 institutional investors held Metacrine, Inc. Common Stock (MTCR) as of Q4 2020, up from 26 in Q3 2020.
  • Funds reported $105M of Metacrine, Inc. Common Stock stock for Q4 2020, down 24% quarter-over-quarter.
  • 23 funds opened new Metacrine, Inc. Common Stock positions in Q4 2020 and 6 closed out, a net change of +17 holders.
  • The largest Metacrine, Inc. Common Stock buyer in Q4 2020 was Franklin Resources, an estimated $6.36M added.
  • The largest Metacrine, Inc. Common Stock seller in Q4 2020 was Deerfield Management, an estimated $5.96M sold.

Based on aggregated 13F filings for Q4 2020.